{"id":2870,"date":"2016-12-28T17:52:33","date_gmt":"2016-12-28T17:52:33","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=19205"},"modified":"2016-12-28T17:52:33","modified_gmt":"2016-12-28T17:52:33","slug":"medical-marijuana-inc-s-year-review-2016-vote-cannabis-reform-8-states-international-expansion-highlights-historic-year","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2016\/12\/28\/medical-marijuana-inc-s-year-review-2016-vote-cannabis-reform-8-states-international-expansion-highlights-historic-year\/","title":{"rendered":"Medical Marijuana, Inc.’s Year in Review: 2016 Vote for Cannabis Reform in 8 States, International Expansion Highlights Historic Year"},"content":{"rendered":"

Company Releases Recap Report of Activities in 2016 and Announces Excitement for Coming Year<\/em><\/h3>\n

SAN DIEGO, CA — (Marketwired) — 12\/28\/16 — Medical Marijuana, Inc.(OTC PINK:MJNA<\/a>)<\/span>, the first-ever publicly traded cannabis company in the United States, today announced the release of a 2016 business year in review posted to their website HERE<\/a>. As you can view HERE<\/a>, Medical Marijuana, Inc. has long been “A Company of First.” 2016 continued to show the company’s progress with many firsts including; receiving the first-ever import permit from the Mexican federal government, receiving the world’s first patented cannabinoid controlled-release chewing gum and becoming the first-ever DEA permit granted to a US-based company to import pharmaceutical grade cannabidiol<\/a>. Additionally, they participated in first-ever events like the Doctors Symposium in Mexico, ExpoMede Weed<\/a> in Medellin, Colombia and Genesis<\/a> in San Diego.<\/p>\n

This recap highlights various exciting business activities and developments within Medical Marijuana, Inc.’s diverse investments and portfolio companies throughout the year and shares the enthusiasm for the future of the Company. The Company began the year with the momentum started in 2015 with legislative reform in the sector and a growing need for access to hemp products throughout the U.S. and around the world.<\/p>\n

HempMeds<\/strong><\/p>\n

Medical Marijuana, Inc<\/a> .<\/a>‘s subsidiary and predominate consumer brand, HempMeds<\/a>\u00ae<\/a> saw a year of massive expansion and continued growth of its line of cannabidiol (CBD) hemp oil products. After receiving the first-ever import permit from Brazil for Real Scientific Hemp Oil\u2122 (RSHO\u2122) in 2014, HempMeds<\/a>\u00ae<\/a> accomplished the first-ever import permits for its RSHO\u2122 and RSHO-X\u2122<\/a> products from the federal governments of Mexico and Paraguay in 2016.<\/p>\n

Operating highlights for 2016 included:<\/strong><\/p>\n